Black afara

Terminalia ivorensis · Accepted scientific name

Scientific literature: Very Extensive (230 studies) · ★★★★★

Black afara, scientifically known as Terminalia ivorensis, is a significant medicinal tree native to West African rainforests. Renowned for its versatile therapeutic properties, various parts of the plant are utilized in traditional medicine to treat ailments such as skin infections, digestive issues, and inflammatory conditions, offering valuable ethnobotanical insights.

Family
Combretaceae
Native range
Africa
Parts used
Leaf · Stem
Common names
Black Afara · Blackbark · 3 more
Scientific synonyms
Not available

Names and Synonyms

Common Names

Scientific Names

Accepted name

Terminalia ivorensis

Regional and Traditional Names

Spanish:

  • Almendro de Costa de Marfil

French:

  • Framiré

Sources: Wikidata, Catalogue of Life

Taxonomical Classification

This plant belongs to the kingdom Plantae and is classified under the phylum Streptophyta and class Equisetopsida. Within the subclass Magnoliidae, it falls under the order Myrtales and is a member of the family Combretaceae. Finally, its taxonomic identity is defined by the genus Terminalia.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Myrtales
Family Combretaceae
Genus Terminalia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

This plant is primarily distributed across the diverse landscapes of West Tropical Africa. Within this broad region, it can be found growing in the country of Benin. Its presence is also documented throughout Burkina Faso. Furthermore, the species extends its reach into the nation of Gambia. Finally, its geographical range includes the territories of both Ghana and Guinea.

Region Area
West Tropical Africa Benin
West Tropical Africa Burkina
West Tropical Africa Gambia
West Tropical Africa Ghana
West Tropical Africa Guinea
West Tropical Africa Ivory Coast
West Tropical Africa Liberia
West Tropical Africa Nigeria
West Tropical Africa Sierra Leone
West-Central Tropical Africa Cameroon

Sources: The World Checklist of Vascular Plants (WCVP)

Botanical Identification

Ecology

The ecology of Terminalia ivorensis is characterized by its specific niche within montane or highland ecosystems, where it thrives within a distinct altitudinal band. This species is primarily distributed across an elevational range that begins at a minimum of 1020 m AMSL and extends up to a maximum of 1500 m AMSL. Occupying these mid-to-high altitude zones, the plant is adapted to the specific microclimatic conditions found in these elevations, which often involve distinct temperature gradients and moisture regimes compared to lowland tropical forests. Its presence within this 480-meter vertical span suggests a specialized dependency on the environmental parameters typical of these highland habitats, influencing its growth patterns and its role within the local biodiversity.

Elevational range max:
1500 m AMSL
Elevational range min:
1020 m AMSL

Life history

The life history of Terminalia ivorenensis is characterized by its existence as a perennial species, ensuring its long-term presence within its ecological niche. As a phanerophyte, the plant maintains its photosynthetic organs on elevated structures, specifically as a phanerophyte that grows in a tree-like habit with buds located well above the ground. Its physiological cycle includes a deciduous phase, during which it sheds its foliage, a strategic adaptation likely tied to seasonal moisture availability or light competition.

Deciduousness :
deciduous
Life form :
phanerophyte
Lifecycle :
perennial

Morphology

The morphology of Terminalia ivorensis is characterized by its stature as a large, woody tree, exhibiting a robust growth form. It is a self-supporting plant that reaches an average height of approximately 30 m, though it can attain a maximum height of up to 45.72 m. As a terrestrial species, it does not exhibit aquatic or semiaquatic tendencies, nor does it function as an epiphyte; instead, it grows independently as a non-parasitic organism. Its structural development is strictly that of a self-supporting tree, lacking any vine, liana, or climbing habits.

Aquatic :
terrestrial
Climber :
self-supporting
Epiphyte :
terrestrial
Growth form :
tree
Parasite :
independent
Plant height max:
45.72055596 m
Plant height mean:
30 m
Woodiness :
woody

Physiology

The physiology of Terminalia ivorensis is characterized by a C3 photosynthetic pathway, which dictates its carbon fixation processes and metabolic efficiency within its natural habitat. As a non-nitrogen-fixing species, the plant does not possess the biological mechanisms to convert atmospheric nitrogen into usable forms through symbiotic relationships, meaning it relies entirely on the uptake of nitrogenous compounds available in the soil to support its growth and nutritional requirements.

Nitrogen fixer :
no
Photosynthetic pathway :
C3

Reproduction

The reproduction of Terminalia ivorensis is characterized by biotic pollination mechanisms, primarily driven by insects, with specific evidence pointing to butterflies as key pollinators. The species does not exhibit self-fertilization, indicating a reliance on cross-pollination to maintain genetic diversity. Once fertilization is successful, the plant utilizes an anemochorous dispersal syndrome, meaning its seeds are dispersed by the wind. The resulting seeds are relatively small, with a mean mass of approximately 0.13316 g, though individual seed weights vary within a range of 0.0909 g to a maximum of 0.16474 g.

Dispersal syndrome :
anemochorous
Pollination syndrome :
insect
Pollination syndrome :
butterfly
Pollination syndrome :
biotic
Seed mass max:
0.16474 g
Seed mass mean:
0.13316 g
Seed mass min:
0.0909 g
Self fertilization :
absent

Sources: Global Inventory of Floras and Traits (GIFT)

Plant Parts

Terminalia ivorensis has 2 reported plant parts identified across 3 scientific publications and several other databases that are studied for medicinal purposes. The most consistently reported plant part include leaf, stem.

Plant parts reported in Terminalia ivorensis
Plant part Supporting sources Consensus
Leaf 2 supporting sources ★☆☆☆☆
Stem 1 supporting sources ★☆☆☆☆

Leaf

  1. Phytotherapy research : PTR
  2. Parasitology research

Stem

  1. Phytotherapy research : PTR

Chemicals

Terminalia ivorensis has 11 reported phytochemicals identified across 3 scientific publications and several other databases. The most consistently reported chemicals include ellagic acid, Coumarins, Flavonoids, GLYCYRRHETINIC ACID, Leucodelphidin.

Chemicals reported in Terminalia ivorensis
Chemical Supporting sources Consensus
ellagic acid 2 supporting sources ★☆☆☆☆
Coumarins 1 supporting sources ★☆☆☆☆
Flavonoids 1 supporting sources ★☆☆☆☆
GLYCYRRHETINIC ACID 1 supporting sources ★☆☆☆☆
Leucodelphidin 1 supporting sources ★☆☆☆☆
Saponins 1 supporting sources ★☆☆☆☆
Sericic acid 1 supporting sources ★☆☆☆☆
Tannins 1 supporting sources ★☆☆☆☆
Terminolic acid 1 supporting sources ★☆☆☆☆
polyphenols 1 supporting sources ★☆☆☆☆

ellagic acid

  1. Dr. Duke
  2. Journal of ethnopharmacology

Coumarins

  1. African health sciences

Flavonoids

  1. African health sciences

GLYCYRRHETINIC ACID

  1. Dr. Duke

Leucodelphidin

  1. Journal of ethnopharmacology

Saponins

  1. African health sciences

Sericic acid

  1. Dr. Duke

Tannins

  1. African health sciences

Terminolic acid

  1. Dr. Duke

polyphenols

  1. African health sciences

Activities

Terminalia ivorensis has 193 reported activities identified across 3 scientific publications and several other databases. The most consistently reported activities include Analgesic, 11B-HSD-Inhibitor, 5-Lipoxygenase-Inhibitor, ACE-Inhibitor, ATPase-Inhibitor.

Activities reported in Terminalia ivorensis
Activity Supporting sources Consensus
Analgesic 3 supporting sources ★★☆☆☆
11B-HSD-Inhibitor 1 supporting sources ★☆☆☆☆
5-Lipoxygenase-Inhibitor 1 supporting sources ★☆☆☆☆
ACE-Inhibitor 1 supporting sources ★☆☆☆☆
ATPase-Inhibitor 1 supporting sources ★☆☆☆☆
Abortifacient 1 supporting sources ★☆☆☆☆
Aldehyde-Oxidase-Inhibitor 1 supporting sources ★☆☆☆☆
Aldose-Reductase-Inhibitor 1 supporting sources ★☆☆☆☆
Allelochemic 1 supporting sources ★☆☆☆☆
Allergenic 1 supporting sources ★☆☆☆☆

Analgesic

  1. Dr. Duke
  2. BMC complementary and alternative medicine
  3. Drug research

11B-HSD-Inhibitor

  1. Dr. Duke

5-Lipoxygenase-Inhibitor

  1. Dr. Duke

ACE-Inhibitor

  1. Dr. Duke

ATPase-Inhibitor

  1. Dr. Duke

Abortifacient

  1. Dr. Duke

Aldehyde-Oxidase-Inhibitor

  1. Dr. Duke

Aldose-Reductase-Inhibitor

  1. Dr. Duke

Allelochemic

  1. Dr. Duke

Allergenic

  1. Dr. Duke

Conditions

Terminalia ivorensis has 11 reported investigations on conditions identified across 3 scientific publications and several other databases. The most consistently reported conditions include malaria, Plasmodium falciparum, analgesic, antioxidant effect, antipyretic.

Conditions investigated for Terminalia ivorensis
Condition Supporting sources Consensus
Malaria 4 supporting sources ★★☆☆☆
Plasmodium falciparum 1 supporting sources ★☆☆☆☆
Analgesic 1 supporting sources ★☆☆☆☆
Antioxidant effect 1 supporting sources ★☆☆☆☆
Antipyretic 1 supporting sources ★☆☆☆☆
Gastroenteritis 1 supporting sources ★☆☆☆☆
Pain 1 supporting sources ★☆☆☆☆
Psychosis 1 supporting sources ★☆☆☆☆
Psychotic disorder 1 supporting sources ★☆☆☆☆
Trypanosoma brucei brucei 1 supporting sources ★☆☆☆☆

Malaria

  1. Phytotherapy research : PTR
  2. Malaria journal
  3. Journal of ethnopharmacology
  4. Parasitology research

Plasmodium falciparum

  1. Malaria journal

Analgesic

  1. BMC complementary and alternative medicine

Antioxidant effect

  1. Journal of evidence-based integrative medicine

Antipyretic

  1. BMC complementary and alternative medicine

Gastroenteritis

  1. Drug research

Pain

  1. Drug research

Psychosis

  1. Drug research

Psychotic disorder

  1. Drug research

Trypanosoma brucei brucei

  1. African journal of traditional, complementary, and alternative medicines : AJTCAM

Preparations

Terminalia ivorensis has 11 reported preparations identified across 3 scientific publications and several other databases. The most consistently reported preparations include extracts, 70% ethanolic 70% extracts of trunk barks, Bon-santé cleanser®, Extracts, aqueous extracts.

Preparations reported for Terminalia ivorensis
Preparation Supporting sources Consensus
Extracts 2 supporting sources ★☆☆☆☆
70% ethanolic 70% extracts of trunk barks 1 supporting sources ★☆☆☆☆
Bon-santé cleanser® 1 supporting sources ★☆☆☆☆
Extracts 1 supporting sources ★☆☆☆☆
Aqueous extracts 1 supporting sources ★☆☆☆☆
Aqueous extracts of trunk barks 1 supporting sources ★☆☆☆☆
Aqueous residue extracts of trunk barks 1 supporting sources ★☆☆☆☆
Crude extracts 1 supporting sources ★☆☆☆☆
Fractions 1 supporting sources ★☆☆☆☆
Leaf extracts 1 supporting sources ★☆☆☆☆

Extracts

  1. Journal of evidence-based integrative medicine
  2. Journal of ethnopharmacology

70% ethanolic 70% extracts of trunk barks

  1. African health sciences

Bon-santé cleanser®

  1. BMC complementary and alternative medicine

Extracts

  1. Malaria journal

Aqueous extracts

  1. Parasitology research

Aqueous extracts of trunk barks

  1. African health sciences

Aqueous residue extracts of trunk barks

  1. African health sciences

Crude extracts

  1. Virology journal

Fractions

  1. Malaria journal

Leaf extracts

  1. Phytotherapy research : PTR